exelon rivastigmine 4.5mg (as hydrogen tartrate) capsule blister pack
novartis pharmaceuticals australia pty ltd - rivastigmine hydrogen tartrate, quantity: 7.2 mg (equivalent: rivastigmine, qty 4.5 mg) - capsule, hard - excipient ingredients: colloidal anhydrous silica; iron oxide red; iron oxide yellow; microcrystalline cellulose; magnesium stearate; gelatin; hypromellose; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; sulfuric acid; purified water; industrial methylated spirit; 2-ethoxyethanol; dimeticone; lecithin - exelon is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.
exelon rivastigmine 3.0mg (as hydrogen tartrate) capsule blister pack
novartis pharmaceuticals australia pty ltd - rivastigmine hydrogen tartrate, quantity: 4.8 mg (equivalent: rivastigmine, qty 3 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; hypromellose; magnesium stearate; titanium dioxide; iron oxide red; iron oxide yellow; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; potassium hydroxide; ammonia; pharmaceutical glaze - exelon is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.
exelon rivastigmine 1.5mg (as hydrogen tartrate) capsule blister pack
novartis pharmaceuticals australia pty ltd - rivastigmine hydrogen tartrate, quantity: 2.4 mg (equivalent: rivastigmine, qty 1.5 mg) - capsule, hard - excipient ingredients: gelatin; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; iron oxide red; ethanol absolute; potassium hydroxide; ammonia; pharmaceutical glaze - exelon is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.
rivastigmine 2mgml oral solution sugar free
rosemont pharmaceuticals ltd - rivastigmine hydrogen tartrate - oral solution - 2mg/1ml
apo-rivastigmine rivastigmine (as hydrogen tartrate) 1.5mg capsule blister pack
arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 2.4 mg - capsule - excipient ingredients: microcrystalline cellulose; stearic acid; gelatin; iron oxide yellow; maize starch; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type
apo-rivastigmine rivastigmine (as hydrogen tartrate) 3mg capsule bottle
arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 4.8 mg - capsule - excipient ingredients: titanium dioxide; microcrystalline cellulose; gelatin; maize starch; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type
apo-rivastigmine rivastigmine (as hydrogen tartrate) 3mg capsule blister pack
arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 4.8 mg - capsule - excipient ingredients: iron oxide red; microcrystalline cellulose; gelatin; iron oxide yellow; stearic acid; titanium dioxide; maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type
apo-rivastigmine rivastigmine (as hydrogen tartrate) 6mg capsule bottle
arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 9.6 mg - capsule - excipient ingredients: gelatin; iron oxide red; stearic acid; titanium dioxide; microcrystalline cellulose; maize starch; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type
apo-rivastigmine rivastigmine (as hydrogen tartrate) 6mg capsule blister pack
arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 9.6 mg - capsule - excipient ingredients: maize starch; microcrystalline cellulose; gelatin; iron oxide red; stearic acid; titanium dioxide; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type
apo-rivastigmine rivastigmine (as hydrogen tartrate) 1.5mg capsule bottle
arrotex pharmaceuticals pty ltd - rivastigmine hydrogen tartrate, quantity: 2.4 mg - capsule - excipient ingredients: titanium dioxide; stearic acid; iron oxide yellow; maize starch; gelatin; microcrystalline cellulose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type